Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib with Rituximab-Bendamustine in R/R DLBCL
NCT04433182Phase 2Terminated
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Aug 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of copanlisib in diffuse large B-cell lymphoma (DLBCL), sponsored by Fondazione Italiana Linfomi. Started Aug 2020; status: terminated.
02
Drugs
copanlisib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT04433182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433182.